Pharma/Biotech News
Subscribe to Pharma/Biotech News
View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Roche Launches Next-Generation Duplex Test for Parovirus B19, Hepatitis A

March 18, 2015 8:56 am | News | Comments

This test is only available in markets accepting the CE mark. Read more...

U.S. Pharmaceutical Market Value Will Approach $550 Billion by 2020: GlobalData

March 17, 2015 12:31 pm | News | Comments

The U.S. pharmaceutical market is forecast to increase from an estimated value of $395.2 billion in 2014 to reach $548.4 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 5.6 percent, according to research and consulting firm GlobalData. Read more..

GSK Announces Start of Phase 3 Program for Retosiban Evaluation

March 17, 2015 8:46 am | News | Comments

Retosiban is an investigational oxytocin antagonist.


UK, Drugmakers Establish $100M Alzheimer's Venture Fund

March 17, 2015 8:32 am | by Linda A. Johnson, AP Business Writer | News | Comments

Major drugmakers, the British government and a top Alzheimer's research charity are pooling more than $100 million to create a global fund to accelerate efforts to find a treatment or even a cure for the mind-robbing disease within a decade. Read more...

Cidara Therapeutics Files for IPO

March 16, 2015 11:18 am | by Ryan Bushey, Associate Editor | News | Comments

The biotech firm based in San Diego is only two years old. Read more...

Amgen's Cholesterol-Lowering Repatha Shows Positive Data

March 16, 2015 10:19 am | News | Comments

Amgen announced new detailed data from the Phase 3 YUKAWA-2 study evaluating Repatha (evolocumab), a novel investigational cholesterol-lowering medication, in Japanese patients with high cardiovascular risk and high cholesterol.  Read more...

Studies Boost Hopes for New Class of Cholesterol Drugs

March 16, 2015 10:00 am | by Marilynn Marchione, AP Chief Medical Writer - Associated Press | News | Comments

New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems. The government will decide this summer whether to allow two of these drugs on the market. Read more...

Valeant, Salix Agree on Amended Terms for Merger Agreement

March 16, 2015 8:40 am | News | Comments

Valeant and Salix Pharmaceuticals announce an amended agreement for its anticipated merger. Read more...


Pfizer Reports Top-Line Results from Phase 4 Study Evaluating Fibromyalgia Capsules

March 16, 2015 8:33 am | News | Comments

The primary endpoint of the study was not achieved as there was not a statistically significant difference between pregabalin and placebo in mean pain score. Read more...

Clinical Trial Review Finds No Increased Risk of Suicide in Patients Using Chantix

March 16, 2015 8:28 am | by University of Bristol | News | Comments

The findings showed no evidence of an increased risk of suicidal behavior. Read more...

Valeant Announces HSR Clearance for Salix Acquisition

March 16, 2015 8:27 am | News | Comments

Valeant expects to be in the position to close the transaction on April 1, 2015. Read more...

Diabetes Drug Shown Not to Increase Heart Failure Risk

March 13, 2015 12:17 pm | by University of Connecticut | News | Comments

People with the most common form of diabetes can take the new drug Alogliptin without concern for an increased risk of heart failure or cardiovascular disease, according to research by a UConn cardiologist published in the British medical journal, The Lancet. Read more..

Actavis Gains FDA Approval for Treatment of Pediatric Bipolar Disorder

March 13, 2015 9:24 am | News | Comments

Approximately 1.2 million children and teens in the United States meet the criteria for bipolar I disorder. Read more...


Washington State Mandate Will Raise Prescription Drug Costs for State Programs, Employers, Unions

March 12, 2015 1:51 pm | News | Comments

A bill (S.B. 5857) in the Washington legislature would force employers, unions, taxpayers, and public programs to pay drugstores more for prescription drugs, the Pharmaceutical Care Management Association (PCMA) said today. Read more...

Genetic Test Maker 23AndMe Launches Drug R&D Effort

March 12, 2015 1:45 pm | by Matthew Perrone, Associated Press | News | Comments

Google-backed genetic testing company 23andMe is launching its own drug development unit, betting that it can translate its database of customer DNA information into novel medicines. Read more...                      

Harder-to-Abuse OxyContin Doesn’t Stop Illicit Use

March 12, 2015 1:40 pm | by Jim Dryden, Washington University in St. Louis | News | Comments

A reformulation of OxyContin that makes it harder to abuse has curtailed the drug’s illicit use. But some 25 percent of drug abusers entering rehab said they still abused the prescription painkiller despite package labeling that emphasizes its abuse-deterrent properties, new research indicates. Read more...

Mylan Launches Generic Antabuse Tablets

March 12, 2015 9:22 am | News | Comments

Mylan received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for this product. Read more...                                                                                                                                   

Swine Flu Outbreak in India Raises Concern

March 12, 2015 9:16 am | by Anne Trafton, MIT | News | Comments

A new study suggests that this strain has acquired mutations that make it more dangerous than previously circulating strains of H1N1 influenza. Read more...                                                                                                

FDA Approves Pediatric Cancer Drug

March 11, 2015 4:24 pm | by Stephanie Guzowski, Editor | News | Comments

The U.S. Food and Drug Administration (FDA) has approved Unituxin (dinutuximab), part of a first-line therapy for high-risk neuroblastoma. Read more..                                  

Endo Proposes Takeover Bid for Salix Pharmaceuticals

March 11, 2015 2:34 pm | by Ryan Bushey, Associate Editor | Articles | Comments

Endo is trying to upset the agreement Valeant Pharmaceuticals made last month to buy Salix. Read more...

Maker of Kids' Tylenol Pleads Guilty Over Metal Particles

March 11, 2015 10:16 am | by Michael Rubinkam and MaryClaire Dale, Associated Press | News | Comments

A subsidiary of Johnson & Johnson pleaded guilty Tuesday to a federal criminal charge that it sold over-the-counter infant's and children's liquid medicine containing metal particles. Read more...                                    

Lhasa Limited Announces Release of Vitic Intermediates Database

March 11, 2015 9:13 am | News | Comments

Members of this database will share mutagenicity data for common intermediates and compounds containing functional groups of interest. Read more...                   

Breakthrough Therapies Target Cancers in 2015

March 11, 2015 8:57 am | by Bevin Fletcher, Associate Editor, Bioscience Technology | Articles | Comments

Getting a new drug to market is difficult, but the U.S. Food and Drug Administration (FDA) offers a number of ways to help the process along for promising drugs that have potential against serious diseases. Read more...

BMG Pharma Launches its Antimicrobial Gel in China

March 11, 2015 8:52 am | News | Comments

The product is called ialuxid gel. Read more...                                   

Takeda Announces Transfer of License Agreement for HPV Vaccine to Kaketsuken

March 11, 2015 8:38 am | News | Comments

Kaketsuken will continue research efforts to support future commercialization of this vaccine. Read more...                         

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.